Insider Option Buying Signals Optimism for Fertility‑Tech Firm
Insider option purchases show cautious optimism for a fertility‑device firm. Despite a steep drop to $0.80, executives are buying stock options, hinting at confidence in upcoming R&D milestones and a potential rebound for investors.
3 minutes to read